The U.S. Patent and Trademark Office (USPTO) published a Federal Register Notice today launching the Streamlined Claim Set ...
Pacira intends to vigorously assert and enforce its intellectual property rights and has 45 days from receipt of the PIV Notice to file a lawsuit if it deems the ANDA filer is infringing its ...
Spotify holds a patent for technology that could generate personalized song mashups. The filing, unearthed by MBW, describes ...
From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drugmakers to account on behalf of patients.
Finding the right patent counsel can be challenging, especially as a small company or solo inventor who does not regularly retain intellectual property rights and lacks a network of contacts. In the ...
The US Supreme Court tossed EcoFactor’s Inc.'s challenge to a Federal Circuit ruling that undid a $20 million ...
Hwa-Kyun Lee and Youngmin Park of FirstLaw explain the country’s strict divisional filing system, the risks of double ...
The Rise of ‘Settled Expectations’ In USPTO Review and the Fallout for Patent Owners and Challengers
The landscape for discretionary denials at PTAB is evolving quickly; both patent challengers and owners must adapt their ...
Since its introduction in 2023, the pro-patent community has broadly supported what the draft Patent Eligibility Restoration ...
On Aug. 28, the B.C. Supreme Court overturned the Residential Tenancy Branch’s decision to allow a B.C. landlord — a numbered ...
From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has received a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback